FRACASSI, Elena
 Distribuzione geografica
Continente #
NA - Nord America 3.776
EU - Europa 3.603
AS - Asia 2.578
SA - Sud America 400
Continente sconosciuto - Info sul continente non disponibili 118
AF - Africa 82
OC - Oceania 8
Totale 10.565
Nazione #
US - Stati Uniti d'America 3.693
RU - Federazione Russa 1.299
SG - Singapore 1.040
GB - Regno Unito 891
CN - Cina 680
IT - Italia 399
BR - Brasile 323
SE - Svezia 214
VN - Vietnam 208
HK - Hong Kong 191
DE - Germania 184
FR - Francia 153
FI - Finlandia 147
IE - Irlanda 146
BD - Bangladesh 112
KR - Corea 74
TR - Turchia 64
JP - Giappone 51
IN - India 50
UA - Ucraina 42
CA - Canada 41
AR - Argentina 27
IQ - Iraq 24
MX - Messico 22
NL - Olanda 21
AT - Austria 19
BE - Belgio 17
ES - Italia 17
ZA - Sudafrica 17
EC - Ecuador 15
NG - Nigeria 15
NP - Nepal 14
PK - Pakistan 13
ID - Indonesia 12
PL - Polonia 11
CO - Colombia 9
BJ - Benin 8
PE - Perù 8
CZ - Repubblica Ceca 7
EG - Egitto 7
MA - Marocco 7
SA - Arabia Saudita 7
AU - Australia 6
IR - Iran 6
JM - Giamaica 6
LT - Lituania 6
TG - Togo 6
VE - Venezuela 6
CH - Svizzera 5
GR - Grecia 5
KE - Kenya 5
PY - Paraguay 5
CL - Cile 4
LB - Libano 4
UZ - Uzbekistan 4
BG - Bulgaria 3
BO - Bolivia 3
GT - Guatemala 3
RO - Romania 3
SI - Slovenia 3
SV - El Salvador 3
TH - Thailandia 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GE - Georgia 2
JO - Giordania 2
KG - Kirghizistan 2
KW - Kuwait 2
PH - Filippine 2
PT - Portogallo 2
TN - Tunisia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BS - Bahamas 1
BT - Bhutan 1
CD - Congo 1
CM - Camerun 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LV - Lettonia 1
LY - Libia 1
ML - Mali 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
Totale 10.441
Città #
Southend 767
Singapore 579
Moscow 455
Ashburn 413
San Jose 374
Chandler 329
Dallas 322
Jacksonville 288
Hong Kong 187
Ann Arbor 174
Dublin 146
Council Bluffs 140
Woodbridge 132
Beijing 126
Verona 125
The Dalles 108
Houston 101
Los Angeles 90
New York 89
Ho Chi Minh City 73
Wilmington 55
Lawrence 54
Princeton 54
Hanoi 49
Jinan 49
Milan 49
Tokyo 47
Munich 39
Nanjing 37
Shenyang 36
São Paulo 34
Helsinki 33
Santa Clara 32
Redmond 30
Buffalo 28
Redondo Beach 24
Turku 23
London 20
Zhengzhou 20
Columbus 19
Tianjin 19
Ningbo 18
Orem 18
Haikou 17
Hebei 17
Brooklyn 16
Brussels 16
Changsha 16
Boardman 15
Boston 15
Phoenix 15
Sindelfingen 15
Abuja 14
Amsterdam 14
Atlanta 14
Falkenstein 14
Fuzhou 14
Taizhou 14
Jiaxing 13
Montreal 13
Taiyuan 13
Chicago 12
Johannesburg 12
Redwood City 12
Rio de Janeiro 12
Baghdad 11
Kathmandu 11
Nanchang 11
Rome 11
San Francisco 11
Seattle 11
Chennai 10
Da Nang 10
Denver 10
Frankfurt am Main 10
Guangzhou 10
Lappeenranta 10
Washington 10
Düsseldorf 9
Hangzhou 9
Lancaster 9
Mexico City 9
Orani 9
Poplar 9
Vienna 9
Ankara 8
Belo Horizonte 8
Cagliari 8
Cotonou 8
Detroit 8
Jakarta 8
Stockholm 8
Charlotte 7
Manchester 7
Norwalk 7
Sanayi 7
Toronto 7
Warsaw 7
Brasília 6
Dongguan 6
Totale 6.427
Nome #
Gender differences in clinical features and quality of life of patients with axial spondyloarthritis and psoriatic arthritis 276
Artrite Reumatoide e Metabolismo Minerale 274
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 257
25-hydroxyvitamin D levels in healthy premenopausal wome: association with bone turnover markers and bone mineral density 248
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 224
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 220
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 211
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 210
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 207
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 190
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 185
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 183
Osteopetrosi 181
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 174
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 173
Calcio e derivati della vitamina D, terapia sostitutiva, calcitonina, fluoruri, bisfosfonati 171
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 171
Depression is associated with increased disease activity and higher disability in a large Italian cohort of patients with rheumatoid arthritis 170
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 170
Coping strategies, emotional distress and perceived disease severity in a cohort of patients with rheumatoid arthritis: a mediation analysis 168
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 166
Sclerostin and DKK1 in primary hyperparathyroidism. 166
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 163
Artropatie degenerative 163
Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women. 161
Prevalence of osteoporosis in patients affected by mastocytosis 158
Development and First Validation of a Disease Activity Score for Gout 157
Invecchiamento dell'apparato scheletrico 154
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 153
Focal bone involvement in inflammatory arthritis: the role of IL17 149
Vitamina D e artrite reumatoide 145
Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol 145
Prevalence and Factors Associated with Subclinical Left Ventricular Systolic Dysfunction Evaluated by Mid-Wall Mechanics in Rheumatoid Arthritis 144
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 143
Permanent Discontinuation of Glucocorticoids in Polymyalgia Rheumatica is Uncommon but May Be Enhanced by Amino Bisphosphonates 140
Clinical and psychological characteristics associated with negative beliefs and concerns about treatment necessity in rheumatic diseases 139
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 139
Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃. 138
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 138
Changes in bone turnover markers and bone modulators during abatacept treatment 137
Osteoporosi 133
Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data 131
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 131
Long-term consequences of a treatment course with bisphosphonates in primary hyperparathyroidism 130
Comparison and potential determinants of health-related quality of life among rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: A cross-sectional study 130
Long-term effects of neridronate and its discontinuation in patients with primary hyperparathyroidism 129
Previous use of amino-bisphosphonates and circulating gamma/delta T cells 126
Depression as a possible determinant of fatigue in patients with axial spondyloarthritis 124
Neridronic acid for the treatment of bone metabolic diseases 124
Vitamin D and rheumatic diseases. 124
Osteoporosis Treatment: When to Discontinue and When to Re-start 122
Efficacy and safety of digital nerve block for pain management during sharp debridement of digital ulcers in systemic sclerosis: A prospective observational study 118
Vitamin D and fractures: a systematic review 117
Marked increases in bone mineral density and biochemical markers of bone turnover in patients with anorexia nervosa gaining weight 114
The waning of teriparatide effect on bone formation markers in postmenopausal osteoporosis is associated with increasing serum levels of DKK1 113
Usefulness of CHA2 DS2 -VASc score to predict mortality and hospitalization in patients with inflammatory arthritis 113
Rational and results of weekly treatment with calcidiol in postmenopausal and senile osteoporosis 110
Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture. 107
Risk factors for hip fracture in elderly persons 104
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis 99
Glucocorticoid sparing effect of Janus Kinase inhibitors compared to biological Disease Modifying Anti-Rheumatic Drugs in rheumatoid arthritis, a single-center retrospective analysis 98
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis? 97
Risk factors for hip fracture in elderly persons 96
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort 94
Treatment with secukinumab in multi-comorbid patients with psoriatic arthritis 94
Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement 92
Gender differences in psychological features and determinates of quality of life in axial spondyloarthritis and psoriatic arthritis: a cross-sectional study 92
Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis 92
The volumetric bone density and cortical thickness in adult patients affected by osteogenesis imperfecta. 92
Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study 91
Rational and results of weekly treatment with calcidiol in postmenopausal and senile osteoporosis,Razionale e risultati del trattamento settimanale con calcifediolo nell'osteoporosi postmenopausale e senile 88
Perforating dermatosis in a young female patient receiving adalimumab biosimilar CTP-17 for chronic plaque psoriasis: A case report 74
Coping strategies, depression, anxiety and fatigue in rheumatic diseases: A moderated mediation analysis 5
Totale 10.565
Categoria #
all - tutte 36.538
article - articoli 33.440
book - libri 0
conference - conferenze 689
curatela - curatele 0
other - altro 465
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.944
Totale 73.076


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022289 0 0 12 13 27 19 7 23 44 7 38 99
2022/2023998 70 107 84 177 54 244 11 68 122 17 33 11
2023/2024539 23 30 43 53 70 94 23 65 7 14 75 42
2024/20251.499 71 79 73 223 79 60 90 66 223 133 129 273
2025/20264.621 306 256 321 828 1.104 316 448 237 283 214 146 162
2026/2027204 78 126 0 0 0 0 0 0 0 0 0 0
Totale 10.565